Heart Failure Medication Approved

The FDA has awarded a further implication for dapagliflozin (Farxiga, AstraZeneca Pharmaceuticals), heart failure medication, the first sodium-glucose co-transporter 2 (SGLT2) inhibitor to be allowed…



COVID-19 Blocking Antibody

The investigators at Utrecht University, Erasmus Medical Center, and Harbour BioMed (HBM) today announced that they had known a fully human monoclonal COVID-19 blocking antibody…


A New NYU Investigation vs. COVID-19

The analysis from New York University (NYU) Grossman School of Medicine has discovered no link between therapy with four medication classes—angiotensin-converting enzyme (ACE) inhibitors, angiotensin…






Old Medications Against Coronavirus

A “medication repurposing” approach uncovers dozens of old medications against coronavirus with the astonishing potential to fight the virus. In the early 1950s, doctors began…